Search Results

Displaying Results 6851-6875 of 8009 "'III'"

Dec 04, 2025, 09:00 ET If you were enrolled in a recurring billing program for certain consumer products from 2009 to present, you may be entitled to benefits from a Settlement

Administrator will reject claims if they, for example: (i) contain significant indicators of fraud, (ii) are untimely, or (iii) are incomplete (Class members will have an opportunity to provide complete information), to ensure the integrity of the Claims Process. 

More news about: The United States District Court for the Southern District of California


Dec 04, 2025, 09:00 ET Si estuvo inscrito en un programa de facturación recurrente para ciertos productos de consumo desde 2009 hasta la actualidad, puede tener derecho a los beneficios de un Acuerdo

El Administrador del Acuerdo rechazará las reclamaciones si, por ejemplo: (i) contienen indicadores significativos de fraude, (ii) son inoportunas o (iii) están incompletas (los miembros del Grupo tendrán la oportunidad de proporcionar información completa), para garantizar la integridad del Proceso de

More news about: The United States District Court for the Southern District of California


Dec 04, 2025, 08:46 ET Tiger Group Offers Rental-Ready Audiovisual Gear from Stray Angel Films

USM lens(1) Canon 14mm f2.8 II EF L Series lens(1) Canon 85mm f/1.2 L II USM autofocus lens(1) 16-35mm f2.8 Canon L Series III Zoom Lens(1) Canon 35mm f/1.4 L II Series Prime lens(1) 24-70mm f/2.8 Canon L Series II zoom lens(1) Canon 24mm T/1.4 Series

More news about: Tiger Group


Dec 04, 2025, 08:38 ET Learning Ally Welcomes Education Leader Lynne Munson to Board of Directors

achieve their potential."Lynne's perspective and expertise will be invaluable as Learning Ally continues to expand its impact," said Howard Bell III, CEO of Learning Ally. "Her leadership aligns deeply with our mission to ensure every learner has the tools they need to read, learn, and thrive."About

More news about: Learning Ally


Dec 04, 2025, 08:37 ET Citius Oncology Expands LYMPHIR™ Distribution to Turkey and Middle East Countries Through Exclusive Agreement with Er-Kim

receptor-directed cytotoxin, approved by the U.S. Food and Drug Administration (FDA) for the treatment of adult patients with relapsed or refractory Stage I-III cutaneous T-cell lymphoma after at least one prior systemic therapy. Under the terms of the agreement, Er-Kim will be the exclusive distributor of LYMPHIR

More news about: Citius Oncology, Inc.


Dec 04, 2025, 08:34 ET LIGHTSPEED 證券集體訴訟達成和解協議,發佈賠償申索公告

1-888-350-7708)索取。若閣下未能在 2026 年 3 月 4 日限期前提交填妥的表格,將無法分獲任何和解金淨額。法院已委任 Concilia Services Inc. 為和解管理人,負責事項包括:(i) 接收及處理申索表格; (ii) 審核賠償資格;及 (iii) 向合資格的訴訟成員發放和解金淨額。申索表格應透過

More news about: Concilia Services Inc.


Dec 04, 2025, 08:19 ET TELUS Announces Cash Tender Offers for Seven Series of Debt Securities

to, or for the account or benefit of, any "U.S. person" (as such term is defined in Regulation S of the U.S. Securities Act of 1933, as amended); or (iii) to participate in the Offers in any jurisdiction in which it is unlawful to make such an offer or solicitation in such jurisdiction, and such persons

More news about: TELUS Corporation


Dec 04, 2025, 08:10 ET ProPharma Welcomes Dan Ryan as President of Clinical Research Solutions

Health. He brings an in-depth understanding of the drug development process, clinical trial conduct, international regulations, and experience in Phase I-III clinical trials, including multi-phase protocol design."ProPharma is uniquely positioned to deliver the kind of operational excellence and scientific

More news about: ProPharma Group Holdings LLC


Dec 04, 2025, 07:07 ET Deck the Aisles with Natural Grocers®: Holly Deals Event, Dec. 6-22, 2025

www.naturalgrocers.com/sweepstakes. Sponsor: Vitamin Cottage Natural Food Markets, Inc.[iii] Offer valid only on 12/20/2025 from 12:00 p.m. – 2:00 p.m. local time, at participating stores, while supplies last.[iv] NO PURCHASE

More news about: Natural Grocers by Vitamin Cottage, Inc.


Dec 04, 2025, 07:03 ET ANKÜNDIGUNG DES VERGLEICHS DER SAMMELKLAGE IN BEZUG AUF LIGHTSPEED-WERTPAPIERE

anderem folgende Aufgaben hat (i) Anspruchsformulare entgegenzunehmen und zu bearbeiten; (ii) über die Berechtigung zur Entschädigung zu entscheiden; und (iii) den Netto-Vergleichsbetrag an die berechtigten Mitglieder der Sammelklägergruppe zu verteilen. Das Antragsformular ist über das sichere Online-Antragssystem

More news about: Concilia Services Inc.


Dec 04, 2025, 07:01 ET Foundral Launches with a Mission to Unite Commercial Contractors Across the Midwest

Capital is a private equity firm based in Chicago, Illinois. The firm is currently investing out of its committed buyout fund, McNally Capital Fund III, LP. The firm seeks thesis-driven buyout investments in the lower middle market across two primary industries: Aerospace & Defense and Industrial

More news about: Foundral


Dec 04, 2025, 07:00 ET Neurimmune expands collaboration with AstraZeneca to develop and commercialize fibril depleter NI009 for AL amyloidosis

leverage Alexion's expertise in AL amyloidosis and strengths in late-stage rare disease drug development and expands upon the two companies' existing Phase III development of cliramitug, an investigational human monoclonal antibody designed to deplete amyloid deposits in ATTR-CM."We are very pleased to

More news about: Neurimmune


Dec 04, 2025, 06:55 ET AVIS DE REGLEMENT DE LA PROCEDURE DE RECOURS COLLECTIF RELATIVE AUX TITRES LIGHTSPEED

règlement pour, entre autres choses : (i) recevoir et traiter les formulaires de réclamation ; (ii) décider de l'éligibilité à l'indemnisation ; et (iii) distribuer le montant net du règlement aux membres du groupe éligibles. Le formulaire de demande d'indemnisation doit être soumis à l'administrateur

More news about: Concilia Services Inc.


Dec 04, 2025, 06:05 ET Paradigm Health Raises $78 Million Series B to Make Clinical Trials Part of Routine Care Across the U.S. and Globally

trials and from health systems seeking to offer trials to patients closer to where they receive routine care. Paradigm Health currently supports Phase I–III oncology trials for 15 of the top 20 global pharmaceutical companies."When trials run more efficiently, new treatments reach patients sooner,"

More news about: Paradigm Health, Inc.


Dec 04, 2025, 06:00 ET NOTICE OF THE SETTLEMENT OF THE CLASS ACTION PROCEEDINGS RELATING TO LIGHTSPEED SECURITIES

Inc. as the Administrator of the settlement to, among other things: (i) receive and process Claim Forms; (ii) decide eligibility for compensation; and (iii) distribute the net settlement amount to eligible Class Members. The Claim Form should be submitted to the Administrator by using the secure online claims

More news about: Concilia Services Inc.


Dec 04, 2025, 06:00 ET NOTICE OF THE SETTLEMENT OF THE CLASS ACTION PROCEEDINGS RELATING TO LIGHTSPEED SECURITIES

Inc. as the Administrator of the settlement to, among other things: (i) receive and process Claim Forms; (ii) decide eligibility for compensation; and (iii) distribute the net settlement amount to eligible Class Members. The Claim Form should be submitted to the Administrator by using the secure online claims

More news about: Concilia Services Inc.


Dec 04, 2025, 06:00 ET AvenCell Therapeutics Announces IND Clearance and EMA Approval of Clinical Trial Application (CTA) for the QUADvance Study, a Phase I/II trial evaluating AVC-203, a Novel Allogeneic CD19/CD20 CAR-T Investigational Therapy for the Treatment of Relapsed/Refractory B-cell malignancies

multimedia:https://www.prnewswire.com/news-releases/avencell-therapeutics-announces-ind-clearance-and-ema-approval-of-clinical-trial-application-cta-for-the-quadvance-study-a-phase-iii-trial-evaluating-avc-203-a-novel-allogeneic-cd19cd20-car-t-investigational-therapy-for-the--302632517.htmlSOURCE

More news about: AvenCell Therapeutics, Inc.


Dec 04, 2025, 03:00 ET iOnctura initiates Phase I/II trial in patients with myelofibrosis ahead of new non-clinical data at ASH

multimedia:https://www.prnewswire.com/news-releases/ionctura-initiates-phase-iii-trial-in-patients-with-myelofibrosis-ahead-of-new-non-clinical-data-at-ash-302632336.htmlSOURCE

More news about: iOnctura


Dec 03, 2025, 20:00 ET Prologis Declares Quarterly Dividend

local economic and political climates and conditions; (ii) changes in global financial markets, interest rates and foreign currency exchange rates; (iii) increased or unanticipated competition for our properties; (iv) risks associated with acquisitions, dispositions and development of properties, including

More news about: Prologis, Inc.


Dec 03, 2025, 17:00 ET 6K ADDITIVE SECURES A$48 MILLION THROUGH INITIAL PUBLIC OFFERING ON THE AUSTRALIAN STOCK EXCHANGE

EXIM Loan builds upon the DPA Title III Grant of US$23.4m to finance the construction of four new buildings and the acquisition of advanced equipment to produce titanium, nickel powders and alloy additions.With the combination of IPO proceeds, the DPA Title III Grant, and the new EXIM Loan, 6K Additive

More news about: 6K


Dec 03, 2025, 16:38 ET A Sustainable Markets Initiative promove uma reunião histórica sobre mobilização de capital privado em Londres, com uma sessão de apresentação de relatórios que contou com a presença de Sua Majestade, o Rei Carlos III

motor de crescimento definidor da próxima década.Sobre a Sustainable Markets Initiative Fundada por Sua Majestade o Rei Charles III, a SMI é a mais proeminente coalizão liderada por CEOs do mundo, acelerando a transição para um futuro sustentável.

More news about: Sustainable Markets Initiative


Dec 03, 2025, 16:34 ET Sustainable Markets Initiative organiza una reunión histórica de transacciones de capital privado en Londres, con una sesión informativa a la que asiste su majestad el rey Carlos III

motor de crecimiento definitivo de la próxima década.Acerca de Sustainable Markets InitiativeFundada por su majestad el rey Carlos III, la SMI es la principal coalición mundial dirigida por directores ejecutivos que acelera la transición hacia un futuro sostenible.

More news about: Sustainable Markets Initiative


Dec 03, 2025, 16:05 ET Brightstar Lottery PLC Announces Successful Pricing of $750,000,000 of Senior Secured Notes Due 2033 and Notice of Redemption of All of Its 6.25% Senior Secured Notes Due 2027

Order")), (ii) falling within Article 49(2)(a) to (d) ("high net worth companies, unincorporated associations, etc.") of the Financial Promotion Order, (iii) who are outside the United Kingdom, or (iv) to whom an invitation or inducement to engage in investment activity within the meaning of Section 21 of

More news about: Brightstar Lottery PLC


Dec 03, 2025, 15:27 ET Global AI and HUMAIN Partner to Accelerate Sovereign AI with Large-Scale NVIDIA-Powered AI Centers

infrastructure. The company is led by deeply seasoned industry veterans, including Co-Founder, Chairman and Chief Technology Officer Dr. John E. Kelly III, an industry veteran who led breakthroughs in semiconductor research, supercomputing, AI, and quantum, and Sami Issa, who co-founded and led AI, GPU

More news about: Global AI


Dec 03, 2025, 12:17 ET Whiteford Taylor & Preston and Peterson Law Release Major Update on Behalf of Dozens of Victims in Deadly Louisville UPS Plane Crash

The litigation is led by Masten Childers III, Kentucky Managing Partner at Whiteford Taylor & Preston, alongside Justin Peterson, Founding Partner of Peterson Law. Their joint team

More news about: Peterson Law


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.